Meet Galderma's New CEO — Dr. Flemming Ørnskov

Описание: Since its formation in 1981, Galderma and its skincare brands have been mainstays of the dermatology world.

Originally formed as a joint venture between Nestlé and L'Oréal, the company later became a wholly-owned subsidiary when, in 2014, Nestlé acquired L'Oréal's 50% stake to form Nestlé Skin Health.

In October of 2019, Nestlé Skin Health was carved out and sold to an investment consortium in a deal valued at 10.2 billion Swiss francs. This move rendered Galderma the largest independent global dermatology company in the world.

New ownership immediately set out to refocus the company as a pure-play dermatology business, restoring the Galderma brand and appointing new leadership, namely CFO Thomas Dittrich and CEO Flemming Ørnskov.

Ørnskov stands among the highest-profile execs in biopharma today. He initially built a reputation for himself as an executive at Bausch & Lomb and Bayer, among others but he is best known for his work as CEO of Shire, where he was credited with growing revenue more than three times over before leading the biotechnology company to a 62-billion-dollar buy out by Japanese multinational pharma company, Takeda.

He qualified as a Doctor of Medicine at the University of Copenhagen Medical School, gained a Master of Public Health (MPH) at Harvard University School of Public Health, and an MBA from INSEAD.

Recently, plastic surgeon and host of The Technology of Beauty podcast, Dr. Grant Stevens, sat down with Dr. Ørnskov for a candid and exclusive interview, in which the new CEO provided a glimpse into his vision and plans for the future of the world's largest independent global dermatology company.